Published in Gene Therapy Weekly, March 30th, 2000
"Genetic modulation of ventricular function may offer a novel therapeutic strategy for patients with congestive heart failure," wrote A.S. Shah and colleagues, Duke University, Medical Center, North Carolina, USA. "Myocardial overexpression of beta(2)-adrenergic receptors (beta(2)ARs) has been shown to enhance contractility in transgenic mice and reverse signaling abnormalities found in failing cardiomyocytes in culture."
Shah et al. published...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.